Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Cost of Revenue: 2017-2021

Historic Cost of Revenue for Neurocrine Biosciences (NBIX) over the last 5 years, with Sep 2021 value amounting to $4.2 million.

  • Neurocrine Biosciences' Cost of Revenue rose 55.56% to $4.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $12.9 million, marking a year-over-year increase of 32.61%. This contributed to the annual value of $7.4 million for FY2019, which is 51.93% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Cost of Revenue of $4.2 million as of Q3 2021, which was up 35.48% from $3.1 million recorded in Q2 2021.
  • In the past 5 years, Neurocrine Biosciences' Cost of Revenue registered a high of $4.2 million during Q3 2021, and its lowest value of $61,000 during Q2 2017.
  • Moreover, its 3-year median value for Cost of Revenue was $2.5 million (2019), whereas its average is $2.5 million.
  • Data for Neurocrine Biosciences' Cost of Revenue shows a peak YoY soared of 1,300.00% (in 2018) over the last 5 years.
  • Quarterly analysis of 5 years shows Neurocrine Biosciences' Cost of Revenue stood at $760,000 in 2017, then soared by 101.84% to $1.5 million in 2018, then soared by 64.80% to $2.5 million in 2019, then rose by 22.73% to $2.7 million in 2020, then skyrocketed by 55.56% to $4.2 million in 2021.
  • Its Cost of Revenue stands at $4.2 million for Q3 2021, versus $3.1 million for Q2 2021 and $2.9 million for Q1 2021.